Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Italy
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2018 2018
- 5 Finished
PASCALE - NUOVI MODELLI ORGANIZZATIVO/GESTIONALI PER LA RICERCA SANITARIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
PASCALE - STRATEGIE TERAPEUTICHE INNOVATIVE NELLA MALATTIA AVANZATA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
PASCALE - PREVENZIONE E FATTORI DI RISCHIO NELLA PATOLOGIA NEOPLASTICA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
Research Output 1977 2019
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer
Avallone, A., Aloj, L., Pecori, B., Caraco, C., De Stefano, A., Tatangelo, F., Silvestro, L., Granata, V., Bianco, F., Romano, C., Di Gennaro, F., Budillon, A., Petrillo, A., Muto, P., Botti, G., Delrio, P. & Lastoria, S., Mar 15 2019, In : Journal of Nuclear Medicine.Research output: Contribution to journal › Article
Fluorodeoxyglucose F18
Chemoradiotherapy
Rectal Neoplasms
Survival
Neoplasms
Abiraterone acetate treatment in patients with castration-resistant prostate cancer with visceral metastases: a real-world experience
Facchini, G., Cavaliere, C., D'Aniello, C., Iovane, G. & Rossetti, S., Feb 2019, In : Anti-Cancer Drugs. 30, 2, p. 179-185 7 p.Research output: Contribution to journal › Article
Castration
Prostatic Neoplasms
Neoplasm Metastasis
Drug Therapy
Prednisone
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer
Caffo, O., Facchini, G., Biasco, E., Ferraù, F., Morelli, F., Donini, M., Buttigliero, C., Calvani, N., Guida, A., Chiuri, V. E., Basso, U., Mucciarini, C., Conteduca, V., Rossetti, S., Veccia, A., Maines, F., Kinspergher, S. & De Giorgi, U., Mar 19 2019, In : Future Oncology.Research output: Contribution to journal › Article
Castration
Cyclophosphamide
Prostatic Neoplasms
Safety
docetaxel